Yuqi Wang

机构：Qingdao University, Tongji University, Shandong University of Traditional Chinese Medicine, Hefei University of Technology, Shandong Normal University, HBIS (China), Qingdao Municipal Hospital, Shijiazhuang Yiling Pharmaceutical (China), Shenzhen Second People's Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-8431-2527

发表论文 82 篇 · 总被引 2363 次 · h-index 24

代表论文

• Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer (2020 · Nature Medicine · 被引 546)
• TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma. (2020 · PubMed · 被引 62)
• LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis (2018 · Cancer Epidemiology Biomarkers & Prevention · 被引 50)
• Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma (2018 · Oncology Reports · 被引 35)
• Human striatal organoids derived from pluripotent stem cells recapitulate striatal development and compartments (2022 · PLoS Biology · 被引 33)
• Technology transfer and global value chain upgrading of manufacturing firms: Evidence from China (2024 · International Review of Economics & Finance · 被引 28)